The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...

At a time when data analysis is increasingly driving research and decision-making, computational analysis, statistical models, computer-based programmes, and other quantitative methods have never been ...

Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies ...